Holen Sie sich die Stockscreener-App
390.90
5.47%
20.26
Vorhandelsmarkt:
398.00
7.10
+1.82%
Schlusskurs vom Vortag:
$370.64
Offen:
$368.26
24-Stunden-Volumen:
1.52M
Relative Volume:
1.06
Marktkapitalisierung:
$56.35B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-238.18
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+11.44%
1M Leistung:
+17.73%
6M Leistung:
+100.17%
1J Leistung:
+118.15%
1-Tages-Spanne:
$365.20
$391.93
1-Wochen-Bereich:
$343.27
$391.93
52-Wochen-Spanne:
$157.43
$391.93
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
390.90 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
658.52 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.09 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
A
Agilent Technologies Inc
|
167.26 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.09 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Why Is Natera (NTRA) Stock Soaring Today - Yahoo Finance
A Look at Natera Inc (NTRA) After 5.5% Gain -- GF Value $219.69 vs Price $390.90 - GuruFocus
Behavioral Patterns of NTRA and Institutional Flows - Stock Traders Daily
Natera Inc stock reaches all-time high at 373.58 USD By Investing.com - Investing.com Nigeria
Natera Inc Stock (NTRA) Moved Up by 5.67% on Sep 22: Facts Behind the Movement - TradingKey
Natera gains as fresh Signatera lung cancer data and upbeat analyst sentiment support shares - quiverquant.com
NTRA Looks 68.7% Overvalued on GF Value™ - GuruFocus
Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Finviz
Natera’s Signatera Receives Japanese Approval as CDx for Muscle-Invasive Bladder Cancer - GenomeWeb
Natera Inc stock reaches all-time high at 373.58 USD - Investing.com
Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027 - tradingview.com
A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment. - Stock Titan
Enterprise value to EBITDA ratio of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA.CI - tradingview.com
Final Trade: Uber, Micron, Natera and Datadog - CNBC
How Lung Cancer Data Will Impact Natera Stock Investors - simplywall.st
Natera, Inc. (NTRA) Stock Analysis: Amidst Rapid Growth, What Lies Ahead for This Diagnostics Leader? - DirectorsTalk Interviews
Natera stock gains as new lung cancer study supports Signatera value - AD HOC NEWS
Natera (NTRA) Study Of 1,100 Patients Supports Signatera In Lung Cancer - simplywall.st
Why Natera (NTRA) Is Up 12.3% After Landmark Lung Cancer MRD Data At IASLC 2026 - Yahoo Finance
Natera (NTRA) Stock Fair Value Rises After Signatera And Guidance Drive Analyst Revisions - Yahoo Finance
Natera CEO Steven Chapman Sells 1,698 Shares for $545,000 - The Motley Fool
A positive result after lung cancer surgery was linked to about 5 times the risk of recurrence - Stock Titan
Show Me The Money: Natera Delivers Over 120% Gain In Just About A Year - RTTNews
Natera co-founder Sheena sells $3.2m in shares - Investing.com
Natera (NASDAQ: NTRA) co-founder sells 9,150 shares under 10b5-1 plan - Stock Titan
Natera(NTRA.US) Director Sells US$3.22 Million in Common Stock - Moomoo
Natera Inc (NTRA) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled - TradingKey
Natera Stock Has Excellent Technical ‘DNA’ as NTRA Sets a New All-Time High - inkl
Natera executive chairman Matthew Rabinowitz sells $34.8m in stock - Investing.com
Natera executive chairman Matthew Rabinowitz sells $34.8m in stock By Investing.com - Investing.com Nigeria
Natera (NASDAQ: NTRA) chair unloads stock in preset plan - Stock Titan
Natera at 2026 Global Healthcare Conference: growth broadens By Investing.com - Investing.com Australia
Natera at 2026 Global Healthcare Conference: growth broadens - Investing.com
Is Natera (NTRA) Fully Priced Or Still A Bargain On Conference Buzz? - simplywall.st
Trust tied to Natera (NASDAQ: NTRA) eyes new stock sale after multimillion-dollar trades - Stock Titan
Natera stock hits all-time high at 343.94 USD By Investing.com - Investing.com Australia
Natera, Inc. (NTRA) Stock Analysis: A $47 Billion Market Cap Powerhouse With A Robust Growth Trajectory - DirectorsTalk Interviews
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy? - The Motley Fool
Understanding Momentum Shifts in (NTRA) - Stock Traders Daily
Did Earnings Beat Just Shift Natera (NTRA) Investment Narrative? - webull.com
Natera(NTRA.US) Officer Sells US$16.4 Million in Common Stock - Moomoo
Natera executive chairman Matthew Rabinowitz sells $16.4m in shares By Investing.com - Investing.com South Africa
Natera executive chairman Matthew Rabinowitz sells $16.4m in shares - Investing.com
Executive chair of Natera (NTRA) sells 50,000 shares - Stock Titan
Insider at Natera (NTRA) plans stock sale, with size detailed in new SEC notice - Stock Titan
NTRA Maintains Buy Rating by UBS -- Price Target Raised to $435 - GuruFocus
3 Reasons Investors Love Natera (NTRA) - Yahoo Finance
UBS Adjusts Price Target on Natera to $435 From $290, Keeps Buy Rating - Moomoo
Jim Cramer Calls Natera (NTRA) “a Promising Story” - Yahoo Finance
Jim Cramer Calls Natera (NTRA) 'a Promising Story': What the Endorsement Signals for Genetic TestingNet Income Trends - careplusvn.com
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | CO-FOUNDER |
Sep 16 '26 |
Sale |
354.19 |
3,150 |
1,115,714 |
221,314 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Sep 15 '26 |
Sale |
347.19 |
50,000 |
17,359,280 |
2,125,394 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Sep 14 '26 |
Sale |
334.76 |
50,000 |
16,737,977 |
2,175,394 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Sep 15 '26 |
Sale |
350.01 |
2,000 |
700,014 |
0 |
3.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):